NEW YORK ─ Sysmex said Tuesday it has obtained marketing approval in Japan for the use of saliva with BGI Genomics' 2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit.
In March, Kobe, Japan-based Sysmex had obtained marketing approval in the country for the distribution of the kit to detect the RNA of SARS-CoV-2 extracted from upper respiratory tract swabs or lower respiratory tract sputum or bronchoalveolar lavage fluids.